Skip to content

Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)

Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05844163
Acronym
ChTUIA
Enrollment
31595
Registered
2023-05-06
Start date
2021-12-01
Completion date
2024-12-01
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unruptured Intracranial Aneurysm

Brief summary

The goal of this prospective observational cohort study is to learn about treatment strategies for unruptured intracranial aneurysms in the Chinese population. The main questions it aims to answer are: * To establish a cohort of patients with intracranial unruptured aneurysm and explore the optimal clinical treatment strategy. * To establish clinical management path for patients with unruptured intracranial aneurysm. According to the treatment of all patients with unruptured intracranial aneurysm, they were divided into the following groups: 1. Conservative treatment group; 2. Intracranial aneurysm clipping group; 3. Coil embolization or stent-assisted coil embolization group; 4. Flow diversion group.

Interventions

OTHERobservation

observation

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER
Huashan Hospital
CollaboratorOTHER
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
First Affiliated Hospital of Fujian Medical University
CollaboratorOTHER
Shanxi Provincial People's Hospital
CollaboratorOTHER_GOV
Peking University First Hospital
CollaboratorOTHER
Peking University Third Hospital
CollaboratorOTHER
Beijing Chao Yang Hospital
CollaboratorOTHER
Beijing Friendship Hospital
CollaboratorOTHER
Beijing Hospital
CollaboratorOTHER_GOV
Anhui Provincial Hospital
CollaboratorOTHER_GOV
The First Affiliated Hospital of Anhui Medical University
CollaboratorOTHER
Binzhou Medical University
CollaboratorOTHER
The Second Affiliated Hospital of Dalian Medical University
CollaboratorOTHER
Xijing hospital of The fourth military medical university
CollaboratorUNKNOWN
Fujian Medical University Union Hospital
CollaboratorOTHER
The First Dongguan Affiliated Hospital of Guangdong Medical University
CollaboratorUNKNOWN
First Affiliated Hospital of Guangxi Medical University
CollaboratorOTHER
The First Affiliated Hospital of Guangzhou Medical University
CollaboratorOTHER
The second People's Hospital of Guiyang
CollaboratorUNKNOWN
The Affiliated Hospital Of Guizhou Medical University
CollaboratorOTHER
Guizhou Provincial People's Hospital
CollaboratorOTHER
Affiliated hospital of Guilin medical university,China
CollaboratorUNKNOWN
National Center for Neurological Disorders (China)
CollaboratorUNKNOWN
First Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
Changhai Hospital, Naval Medical University
CollaboratorUNKNOWN
The Second Affiliated Hospital of Hainan Medical University
CollaboratorOTHER
The Second Hospital of Hebei Medical University
CollaboratorOTHER
Wuhan TongJi Hospital
CollaboratorOTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CollaboratorOTHER
The First Hospital of Jilin University
CollaboratorOTHER
Guangzhou Red Cross Hospital
CollaboratorOTHER
Jiangnan University Medical Center
CollaboratorUNKNOWN
Xunxian People's Hospital
CollaboratorUNKNOWN
The Second Affiliated Hospital of Kunming Medical University
CollaboratorOTHER
First Affiliated Hospital of Kunming Medical University
CollaboratorOTHER
Lanzhou University Second Hospital
CollaboratorOTHER
The Southwest Hospital of Army Medical University
CollaboratorUNKNOWN
Second Affiliated Hospital of Nanchang University
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
CollaboratorOTHER
The General Hospital of Eastern Theater Command
CollaboratorOTHER
Inner Mongolia People's Hospital
CollaboratorOTHER
General Hospital of Ningxia Medical University
CollaboratorOTHER
Qinghai People's Hospital
CollaboratorOTHER
The First Affiliated Hospital of Xiamen University
CollaboratorOTHER
Qilu Hospital of Shandong University
CollaboratorOTHER
Qilu Hospital of Shandong University (Qingdao)
CollaboratorOTHER
Qingdao Municipal Hospital
CollaboratorOTHER
The First Affiliated Hospital of Shanxi Medical University
CollaboratorOTHER
Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University
CollaboratorUNKNOWN
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
CollaboratorUNKNOWN
RenJi Hospital
CollaboratorOTHER
Shenzhen Second People's Hospital
CollaboratorOTHER
The General Hospital of Northern Theater Command
CollaboratorOTHER
Xuanwu Hospital, Beijing
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
Sichuan Provincial People's Hospital
CollaboratorOTHER
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, China
CollaboratorUNKNOWN
Second Affiliated Hospital of Soochow University
CollaboratorOTHER
The First Affiliated Hospital of Soochow University
CollaboratorOTHER
Tangshan Gongren Hospital
CollaboratorOTHER
Tianjin Huanhu Hospital
CollaboratorOTHER
Tianjin Medical University General Hospital
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
Second People's Hospital of Tibet Autonomous Region
CollaboratorUNKNOWN
Tibet Autonomous Region People's Hospital
CollaboratorOTHER
Second Xiangya Hospital of Central South University
CollaboratorOTHER
First Affiliated Hospital of Xinjiang Medical University
CollaboratorOTHER
The Affiliated Hospital of Xuzhou Medical University
CollaboratorOTHER
School of brain science and brain medicine, Zhejiang University
CollaboratorUNKNOWN
The Second Affiliated Hospital Zhejiang University School of Medcine
CollaboratorUNKNOWN
Fifth Affiliated Hospital of Zhengzhou University
CollaboratorUNKNOWN
Chinese PLA General Hospital
CollaboratorOTHER
First Affiliated Hospital of China Medical University
CollaboratorUNKNOWN
Shengjing Hospital
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Chongqing General Hospital
CollaboratorOTHER
First Affiliated Hospital of Chongqing Medical University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

A. age \> 18 years. B. at least one intracranial aneurysm needs to be treated by craniotomy, endovascular treatment or combined surgery. C. patients' consent were obtained.

Exclusion criteria

1. Ruptured intracranial aneurysms, accompanied by subarachnoid hemorrhage or cerebral hemorrhage ; 2. Traumatic, infectious and atrial myxoma-associated intracranial aneurysms ; 3. Combined with cerebrovascular malformations; 4. Combined with brain tumors or malignant tumors in other parts ; 5. Combined with systemic connective tissue disease and systemic rheumatic disease ; 6. Due to other diseases, or poor general condition, the expected survival time is not more than 12 months ; 7. During pregnancy and perinatal period.

Design outcomes

Primary

MeasureTime frameDescription
Primary Outcome2 yearsFunctional outcomes(modified Rankin Scale,mRS) at 2 years after treatment decision

Secondary

MeasureTime frameDescription
MACCE events1 yearsIncidence of major adverse cardiovascular/cerebrovascular events (MACCE events) in patients with atherosclerotic heart disease within 1 year after treatment decision.
cardiovascular/cerebrovascular events2 yearsIncidence of cardiovascular/cerebrovascular events in 2 years after receiving different treatment strategies.
Cost2 yearsCosts associated with unruptured intracranial aneurysms within 2 years after treatment with different strategies.
Aneurysm-related bleeding events2 yearsIncidence of aneurysmal-related bleeding events within 2 years after receiving different treatment strategies.
Mortality associated with intracranial aneurysms2 yearsMortality associated with intracranial aneurysms within 2 years after treatment with different strategies
All-cause mortality2 yearsAll-cause mortality of patients within 2 years after different treatment strategies.

Countries

China

Contacts

STUDY_CHAIRWang shuo, M.D.

Beijing Tiantan Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026